nach oben

Erschienen in:

19.08.2016 | General Gynecology

The effect of contraceptive methods on reproductive tract infections risk: a cross-sectional study having a sample of 52,481 women

verfasst von: Li-Ya Wang, Le OuYang, Fei Tong, Xiu-Jun Zhang, Xiu-De Li, Cheng-Cheng Wang, Xiang Li, Liang Sun, Ye-Huan Sun

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Objective

The aim of this study was to investigate the association between specific contraceptives use and reproductive tract infections (RTIs).

Study design

Participants consisted of 52,481 rural married women of reproductive age identified from a cross-sectional study in Anhui Province of China. The questionnaire, gynecological examination, and laboratory inspection were used to collect data. The subgroup analysis was performed to estimate the effect of the specific contraceptives on the specific RTIs.

Results

A total of 49,970 (95.2 %) women used contraceptive methods and 31,390 (59.8 %) women had at least one RTI. Overall, use of intrauterine device (IUD), condom, female sterilisation, rhythm method, and oral contraceptive (OC) were associated with RTIs. In the subgroup analysis, IUD use was a risk factor for endocervicitis, bacterial vaginosis (BV), and trichomoniasis; condom, rhythm method, and OC were associated with endocervicitis; female sterilisation was associated with endocervicitis and trichomoniasis. Moreover, male sterilisation was associated with endocervicitis; withdrawal was a protective factor for endocervicitis and a risk factor for trichomoniasis; subdermal implant was associated with candidiasis and pelvic inflammatory disease (PID).

Conclusions

All the contraceptive methods may lead to the RTIs. A properly assessment for contraceptive methods use is needed for female reproductive health.

Wang C (2012) History of the Chinese family planning program: 1970–2010. Contraception 85:563–569CrossRefPubMed

Zhang XJ, Wang GY, Shen Q et al (2009) Current status of contraceptive use among rural married women in Anhui Province of China. BJOG 116:1640–1645CrossRefPubMed

Li J, Temmerman M, Chen Q, Xu J, Hu L, Zhang WH (2013) A review of contraceptive practices among married and unmarried women in China from 1982 to 2010. Eur J Contracept Reprod Health Care 18:148–158CrossRefPubMed

Madden T, Grentzer JM, Secura GM, Allsworth JE, Peipert JF (2012) Risk of bacterial vaginosis in users of the intrauterine device: a longitudinal study. Sex Transm Dis 39:217–222CrossRefPubMedPubMedCentral

Li XD, Wang CC, Zhang XJ et al (2014) Risk factors for bacterial vaginosis: results from a cross-sectional study having a sample of 53,652 women. Eur J Clin Microbiol Infect Dis. doi:10.1007/s10096-014-2103-1

Slaymaker E (2004) A critique of international indicators of sexual risk behaviour. Sex Transm Infect 80(Suppl 2):ii13–ii21PubMedPubMedCentral

Mayaud P, Mabey D (2004) Approaches to the control of sexually transmitted infections in developing countries: old problems and modern challenges. Sex Transm Infect 80:174–182CrossRefPubMedPubMedCentral

Zhang XJ, Shen Q, Wang GY et al (2009) Risk factors for reproductive tract infections among married women in rural areas of Anhui Province, China. Eur J Obstet Gynecol Reprod Biol 147:187–191CrossRefPubMed

Maharlouei N, Barooti E, Sharif F, Hosseini H, Lankarani KB (2013) Prevalence and risk factors of reproductive tract infections among a defined population of Iranian women. Sex Health 10:311–315CrossRefPubMed

10.

Office for the Sixth Population Census of Anhui Province. Tabulation on the 2010 population census of Anhui Province. China Statistics Press, Beijing. 2012

11.

Prasad JH, Abraham S, Kurz KM et al (2005) Reproductive tract infections among young married women in Tamil Nadu, India. Int Fam Plan Perspect 31:73–81CrossRefPubMed

12.

Baris II, Arman Karakaya Y (2013) Effects of contraception on cervical cytology: data from Mardin City. Turk Patoloji Derg 29:117–121PubMed

13.

Harikarnpukdee D, Sirimai K, Kiriwat O, Boriboonhirunsarn D (2004) Prevalence of bacterial vaginosis among intrauterine device users in Thai women attending family planning clinic, Siriraj Hospital. J Med Assoc Thai 87(Suppl 3):S8–S11PubMed

14.

Calzolari E, Masciangelo R, Milite V, Verteramo R (2000) Bacterial vaginosis and contraceptive methods. Int J Gynaecol Obstet 70:341–346CrossRefPubMed

15.

Kazerooni T, Mosalaee A (2002) Does contraceptive method change the Pap smear finding? Contraception 66(4):243–246CrossRefPubMed

16.

Barbone F, Austin H, Louv WC, Alexander WJ (1990) A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis. Am J Obstet Gynecol 163:510–514CrossRefPubMed

17.

Faundes A, Telles E, Cristofoletti ML, Faundes D, Castro S, Hardy E (1998) The risk of inadvertent intrauterine device insertion in women carriers of endocervical Chlamydia trachomatis. Contraception 58:105–109CrossRefPubMed

18.

Kaliterna V, Kučišec-Tepeš N, Pejković L, Zavorović S, Petrović S, Barišić Z (2011) An intrauterine device as a possible cause of change in the microbial flora of the female genital system. J Obstet Gynaecol Res 37:1035–1040CrossRefPubMed

19.

Campbell SJ, Cropsey KL, Matthews CA (2007) Intrauterine device use in a high-risk population: experience from an urban university clinic. Am J Obstet Gynecol 197:193.e1–193.e6 (discussion 193.e6–7) CrossRef

20.

Baeten JM, Nyange PM, Richardson BA et al (2001) Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am J Obstet Gynecol 185:380–385CrossRefPubMed

21.

Rutherford GW, Anglemyer A, Bagenda D et al (2014) University students and the risk of HIV and other sexually transmitted infections in Uganda: the Crane Survey. Int J Adolesc Med Health 26:209–215CrossRefPubMed

22.

Crosby RA, Milhausen RR, Graham CA et al (2014) Likelihood of condom use when sexually transmitted diseases are suspected: results from a clinic sample. Health Educ Behav. doi:10.1177/1090198114529588 PubMed

23.

Winer RL, Hughes JP, Feng Q et al (2006) Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 354:2645–2654CrossRefPubMed

24.

Beerthuizen R (2010) State-of-the-art of non-hormonal methods of contraception: V. Female sterilisation. Eur J Contracept Reprod Health Care 15:124–135CrossRefPubMed

25.

Guedou FA, Van Damme L, Mirembe F, Solomon S, Becker M, Deese J et al (2012) Intermediate vaginal flora is associated with HIV prevalence as strongly as bacterial vaginosis in a cross-sectional study of participants screened for a randomised controlled trial. Sex Transm Infect 88:545–551CrossRefPubMed

26.

Riggs M, Klebanoff M, Nansel T, Zhang J, Schwebke J, Andrews W (2007) Longitudinal association between hormonal contraceptives and bacterial vaginosis in women of reproductive age. Sex Transm Dis 34:954–959PubMed

27.

Zite N, Borrero S (2011) Female sterilisation in the United States. Eur J Contracept Reprod Health Care 16:336–340CrossRefPubMed

28.

Keramat A, Zarei A, Arabi M (2011) Barriers and facilitators affecting vasectomy acceptability (a multi stages study in a sample from north eastern of Iran), 2005–2007. Asia Pac Fam Med 10:5CrossRefPubMedPubMedCentral

29.

Djerassi C (1990) Fertility awareness: jet-age rhythm method? Science 248:1061–1062CrossRefPubMed

30.

Koumans EH, Sternberg M, Bruce C, McQuillan G, Kendrick J, Sutton M et al (2007) The prevalence of bacterial vaginosis in the United States, 2001–2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis 34:864–869CrossRefPubMed

31.

Bovens L (2006) The rhythm method and embryonic death. J Med Ethics 32:355–356CrossRefPubMedPubMedCentral

32.

Nguyen TV, Khuu NV, Truong PH, Nguyen AP, Truong LX, Detels R (2009) Correlation between HIV and sexual behavior, drug use, trichomoniasis and candidiasis among female sex workers in a Mekong Delta province of Vietnam. AIDS Behav 13:873–880CrossRefPubMed

33.

Roy S (1991) Nonbarrier contraceptives and vaginitis and vaginosis. Am J Obstet Gynecol 165(4 Pt 2):1240–1244CrossRefPubMed

34.

Pettifor A, Delany S, Kleinschmidt I, Miller WC, Atashili J, Rees H (2009) Use of injectable progestin contraception and risk of STI among South African women. Contraception 80:555–560CrossRefPubMedPubMedCentral

35.

Schwebke JR, Hillier SL, Sobel JD, McGregor JA, Sweet RL (1996) Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis. Obstet Gynecol 88(4 Pt 1):573–576CrossRefPubMed

Titel: The effect of contraceptive methods on reproductive tract infections risk: a cross-sectional study having a sample of 52,481 women
verfasst von: Li-Ya Wang
Le OuYang
Fei Tong
Xiu-Jun Zhang
Xiu-De Li
Cheng-Cheng Wang
Xiang Li
Liang Sun
Ye-Huan Sun
Publikationsdatum: 19.08.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: Archives of Gynecology and Obstetrics / Ausgabe 6/2016
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-016-4172-0

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

The effect of contraceptive methods on reproductive tract infections risk: a cross-sectional study having a sample of 52,481 women